DGAP-CMS: Correction of a release from 11/02/2019, 10:48 CET/CEST - CompuGroup Medical SE: Release of a capital market information

2019. március 19., kedd, 08:39





DGAP Post-admission Duties announcement: CompuGroup Medical SE / Share Buyback


Correction of a release from 11/02/2019, 10:48 CET/CEST - CompuGroup Medical SE: Release of a capital market information


19.03.2019 / 08:39


Dissemination of a Post-admission Duties announcement transmitted by DGAP - a service of EQS Group AG.


The issuer is solely responsible for the content of this announcement.


CompuGroup Medical SE: Disclosure pursuant to Art. 5 Para. 1 lit. b) and
Para. 3 of the Regulation (EU) No 596/2014 (MAR) in conjunction with Art. 2
Para. 2 and Para. 3 of the Commission Delegated Regulation (EU) No
2016/1052 - 8th Interim Announcement

CompuGroup Medical SE / Share Buyback


Koblenz, March 19, 2019

CompuGroup Medical SE: Disclosure pursuant to Art. 5 Para. 1 lit. b) and
Para. 3 of the Regulation (EU) No 596/2014 (MAR) in conjunction with Art. 2
Para. 2 and Para. 3 of the Commission Delegated Regulation (EU) No
2016/1052 - 8th Interim Announcement

In the period from February 4, 2019, up to and including February 8, 2019,
CompuGroup Medical SE has bought back a total of 35,417 shares of
CompuGroup Medical SE within the framework of the share buyback program. In
the announcement of December 14, 2018, pursuant to Art. 2 para. 1 of the
Commission Delegated Regulation (EU) 2016/1052 supplementing Regulation
(EU) No 596/2014 (MAR) it was communicated that the repurchase of treasury
shares would commence on December 17, 2018.

The overall volume of the shares bought back daily in the period from
February 4, 2019, up to and including February 8, 2019, and the daily
volume-weighted average stock market prices of the shares are as follows:



































DateOverall volume ofVolume-weighted average

shares bought backstock market price

(number)(EUR, excluding ancillary


costs of purchase, rounded


to four places according to


commercial practice)
February 4, 20192,53447.5930
February 5, 20197,02148.2803
February 6, 20196,40048.7610
February 7, 201910,81248.8011
February 8, 20198,65048.6567
In total:35,41748.5689











The total number of shares which have been bought back so far by CompuGroup
Medical SE since December 17, 2018, up to and including February 8, 2019,
within the framework of the share buyback program thus amounts to 223,989
no-par value shares.

Further information pursuant to Art. 5 para. 1 lit. b) and para. 3 of the
Regulation (EU) No 596/2014 (MAR) in conjunction with Art. 2 para. 2 and
para. 3 of the Commission Delegated Regulation (EU) No 2016/1052 is
available online under https://www.cgm.com/sbb.

The purchase of the shares of CompuGroup Medical SE was carried out by a
bank assigned by CompuGroup Medical SE and exclusively via the Frankfurt
Stock Exchange (Xetra trading).

Koblenz, March 19, 2019

The Management Board

CompuGroup Medical SE

Investor Relations

Maria Trost 21

56070 Koblenz, Germany

T: 49 (0) 261 8000-6200

F: 49 (0) 261 8000-3200














19.03.2019 The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
Archive at www.dgap.de












Language: English
Company: CompuGroup Medical SE

Maria Trost 21

56070 Koblenz

Germany
Internet: www.cgm.com





 
End of News DGAP News Service




788895  19.03.2019 



fncls.ssp?fn=show_t_gif&application_id=788895&application_name=news&site_id=geo_holding_tug
Tilos a hír bármilyen adatbázisba történő mentése vagy annak továbbítása harmadik fél számára;kereskedelmi viszonylatban vagy kereskedelmi céllal csak a Deutsche Gesellschaft für Ad-hoc-Publizität mbh írásos engedélyével történhet.

Közzétételek - archívum